Anti-MDA-5 positive patients are characterized by a skin rash, often with signs of skin vasculopathy and ulcerating skin lesions (typically at the palmar surface of the hands), polyarthritis and rapid ILD with a high mortality rate (between 33–67%) [85,87,88,89,90,91]. This evidence concerns the gene IFIH1 and interstitial lung disease.